Identification of a target antigen in human anti-tubular basement membrane nephritis  by David Fliger, F. et al.
Kidney International, Vol. 31 (1987), pp. 800—807
Identification of a target antigen in human anti-tubular
basement membrane nephritis
F. DAVID FLIGER, JORGEN WIESLANDER, JAN R. BRENTJENS, GIUSEPPE A. ANDRES,
and RALPH J. BUTKOWSKI
Department of Anatomy, University of Kansas Medical Center, Kansas City, Kansas, and Department of Pathology, State University of New
York, University of Buffalo, Buffalo, New York, USA
Identification of a target antigen In human anti-tubular basement
membrane nephritis. Sera from two patients with primary anti-
tubular—basement—membrane—mediated tubulointerstitial nephritis, one
a renal allograft recipient and the other with spontaneous anti-
tubular—basement—membrane disease, were analyzed for the specificity
of their autoantibodies. Both sera had circulating antibodies that
reacted by ELISA with extracts of tubular basement membrane from
several species, but failed to react significantly with extracts of glomer-
ular basement membrane. Reactive antigen was solubilized with 6 M
guanidine-HCI, 6 M urea, with reduction and alkylation, and with
sodium dodecylsulfate. Digestion of the basement membrane with
collagenase released relatively small quantities of antigen from the
membrane, and trypsin and pepsin destroyed its antigenicity. The
antigenic activity was characterized with respect to its size distribution
by gel filtration and by immuno-overlay analysis of protein blots.
Collectively, the results indicate that the major reactivity of both sera is
directed towards a Mr 58,000 component that is unique to the tubular
basement membrane. Minor reactivities toward high molecular weight
components common to both glomerular and tubular basement mem-
branes were detected by immuno-overlay analysis. This study identifies
an antigen that is involved in human anti-tubular—basement—membrane-
mediated tubulointerstitial nephritis, and demonstrates an advantage of
the use of denaturing extraction over proteolytic methods to prepare the
antigen.
The first animal model of tubulointerstitial nephritis (TIN)
induced by antibodies reactive with the basement membrane of
proximal tubules (TBM) was developed in 1971 by Steblay and
Rudofsky in guinea pigs immunized with rabbit TBM [I].
Immunofluorescence analysis of the kidneys from immunized
animals revealed linear deposition of IgG along the TBM but
not along the glomerular basement membrane (GBM) or
Bowman's capsule. Passive transfer of IgG from immunized
animals to naive guinea pigs induced TIN comparable to that
seen in immunized animals [2—4]. Passive transfer of lymph
node cells from immunized animals to normal animals failed to
elicit tubular damage [3]. Bovine TBM administered to guinea
pigs in conjunction with cyclophosphamide led to the conclu-
sion that anti-TBM antibodies were the mediating factor of TIN
in this model [5]. A similar model was developed in Brown!
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Norway or Lewis X Brown/Norway Fl hybrid rats immunized
with bovine TBM [6].
GBM has also been used as an immunogen to induce
nephritides in animals. In one study, immunization with GBM
resulted in tubular damage followed, 14 days later, by glomer-
ular damage [7]. Other studies demonstrated that immunization
with heterologous GBM led to the production of antibodies
directed to GBM and TBM, whereas immunization with IBM
produced antibodies against TBM only [8—111. Conclusions
drawn from these studies were that GBM was eliciting re-
sponses to common domains of type IV procollagen and IBM
immunization was resulting in responses to noncollagenous
glycopeptides present in TBM only.
Several studies have been performed on the isolation and
analysis of nephritogenic antigens from TBM. Graindorge and
Mahieu [12] digested human TBM with collagenase, and iso-
lated a Mr 70,000 protein from the solubilized material. Its
amino acid and carbohydrate composition was characterized,
and it was used to establish a radioimmunologic assay for TBM
antigen. In that assay, nine of II patients with glomerulonephri-
tis, where linear staining of both GBM and TBM was observed,
had detectable antibodies toward the TBM antigen. Further-
more, sera from two patients with TBM antibodies that ap-
peared secondarily to an immune—complex glomerular disease
associated with a nephrotic syndrome demonstrated reactivity
toward the purified protein. Wakashin et al [11] isolated a
trypsin solubilized protein (Mr 30,000) from human TBM, and
used it as an immunogen to generate autoimmune renal disease
in goats and mice. The TBM of goat, guinea pig, mouse and man
all reacted with the antibodies toward the human TBM antigen
by indirect immunofluorescence indicating a shared specificity
among species. Zanetti and Wilson identified a molecule pre-
cipitated by TBM antibodies from Brown/Norway rats immu-
nized with bovine TBM [13]. This molecule, obtained from
TBM by collagenase digestion, had a molecular weight of
42,000 by SDS-PAGE. The antigen was present in the Brown-
/Norway, but not in the nonsusceptible Lewis strain and was
proposed to be important in triggering autoantibody formation
in this model. A TBM antigen recently isolated by Clayman et
al [14] is a noncollagenous glycoprotein of Mr 48,000. The
protein was prepared by collagenase digestion of the TBM and
was purified by immunoabsorption using a purified monoclonal
antibody. It contains low levels of hydroxyproline, suggesting
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that it could be derived from a collagenous precursor. This
peptide induced TBM-specific antibody formation and renal—
interstitial cell infiltrates in guinea pigs.
The pathogenesis of TIN is, in the majority of patients,
poorly understood. In a small number of patients the disease is
associated with anti-TBM antibodies. Immunofluorescence mi-
croscopy studies of their kidneys reveal the presence of linear
deposits of IgG and complement along the basement membrane
of the tubules. Evidence that these linear deposits are the
consequence of binding in vivo of specific antibodies may come
from the demonstration of anti-TBM antibodies in the serum or
kidney eluates. Anti-TBM antibodies have been reported in
conjunction with anti-glomerular—basement—membrane anti-
body—mediated glomerulonephritis and with immune complex
glomerulonephritis, in patients treated with certain drugs, or
following kidney transplantation [15]. The observation of anti-
TBM antibodies as an isolated phenomenon in patients with
TIN is distinctly rare [16]. Evidence for the pathogenicity of
anti-TBM antibodies in man is obviously difficult to obtain [171.
Final proof can only be provided by experiments aimed at
inducing TIN in suitable laboratory animals by passive transfer
of human anti-TBM antibodies.
The identification and characterization of TBM antigens
involved in human TIN is essential to gain further understand-
ing of the disease process and to correlate with animal models
of the disease. The present study was undertaken in order to
identify TBM antigen(s) reactive with antibodies from patients
with a pure form of TIN. The results indicate that a protein of
Mr = 58,000 binds antibodies in the sera from two patients with
a primary anti-TBM-induced TIN. This protein can be ex-
tracted from TBM in denaturing solvents; thus procedures
leading to its purification can be developed while avoiding
potential problems associated with enzymatic solubilization.
Methods
Human anti-TBM antibodies
Serum used in the present studies was obtained from two
patients. The first patient (TIN-l) was a 27-year—old female,
admitted to the Buffalo General Hospital (Buffalo, New York,
USA) in 1983 because of acute renal failure. Her kidney biopsy
showed TIN with infiltration of the interstitium with mononu-
clear as well as neutrophilic polymorphonuclear leukocytes. By
immunofluorescence microscopy, linear deposits of IgG and C3
were present along the basement membrane of the proximal
tubules. Immune reactants were not found in the glomeruli. The
second patient (TIN-2) was a 36-year—old male with end—stage
kidney disease of unknown origin who received a kidney
allograft in August of 1983. Two months later he was admitted
to the Buffalo General Hospital on suspicion of acute kidney
transplant rejection. The biopsy revealed TIN characterized by
interstitial infiltration of mononuclear cells and a few neutro-
philic polymorphonuclear leukocytes. Immunofluorescence mi-
croscopy studies demonstrated linear deposits of IgG and C3
along the basement membrane of the proximal tubule. Immune
deposits were absent from the glomeruli.
The serum of both patients contained antibodies that reacted
in vitro exclusively with the basement membrane of proximal
tubules of human as well as animal (rabbit, guinea pig, rat,
mouse) kidneys. Differences in reactivity between the sera of
the two patients could not be detected.
Basement membrane
TBM and GBM from human, bovine, Brown/Norway rat, and
rabbit sources were prepared as follows. Human glomeruli and
tubules were prepared by the method of Langeveld et al [18].
This method involves forcing cortical kidney tissue through a
500 im stainless steel sieve and washing it with 0.15 M NaCI
which was 10 m in EDTA, 5 m'vi in epsilon—amino caproic
acid, 5 mrvi in N-ethylmaleimide and 1 mrvi diisopropylfluoro-
phosphate through a series of successively finer sieves. The
glomeruli were trapped on 125 and 106 pin sieves. The tubules
were captured on 45 and 38 sm sieves. The products were
sonicated in 1.0 M NaCl with the above inhibitors included. The
resulting basement membrane was washed three times with the
1.0 M NaCI solution, three times with water, then frozen and
lyophilized. Rat TBM was prepared by the method previously
described [19]; and rabbit TBM was prepared by the method
described [20] using a polytron tissue disruptor instead of
forcing tissue through the coarse sieve.
Antigen solubilization
Basement membrane was extracted overnight in 6 M
guanidine-HCI/0.05 M Tris, pH 7.5 at 37°C in the presence of the
protease inhibitors listed above, excluding the diisopropyl-
fluorophosphate. Other extractions were done at the same
temperature, but using either 6 Murea, 0.05 M Tris-HCI pH 7.5
or 8 M urea, 0.1 M Tris-HCI, pH 7.5 in the presence of protease
inhibitors. In some cases the protein was ethanol precipitated
by adding a tenfold aliquot of alcohol at 0°C followed by
centrifugation. For gel filtration analysis, an 8 M urea, 0.1 M
Tris, pH 7.5 extract was reduced in volume on an Amicon
system using a YM-lO filter and applied to a Sepharose CL-4B
column (2,5 x 90 cm) equilibrated in 6 M urea, 0.1 M sodium
phosphate, pH 7.4. The effluent from the concentration step and
from the gel filtration column was monitored for absorption at
230 nm and for reactivity by ELISA.
Co/Ia genase. Bacterial collagenase (Worthington Biochemi-
cal Corp, Freehold, New Jersey, USA, CLSPA, 540 units/mg or
Advanced Biofactures Corp., 330 tJmg) was dissolved in 50 mivi
HEPES buffer containing 10 mivi CaCl2, 4 mM N-ethylmalei-
mide, 5 mrvi benzamidine-HCI, 25 m epsilon—amino caproic
acid, pH 7.5. Human and rabbit TBM were incubated with 70 ,a
collagenase per mg TBM with stirring at 37°C overnight. The
final concentration of TBM was adjusted to 8 mg/mI by the
addition of HEPES buffer with protease inhibitors.
Pepsin. Porcine stomach mucosal pepsin (Sigma Chemical
Co., St. Louis, Missouri, USA, 3200 units/mg) was dissolved in
0.5 N acetic acid to a concentration of I mg/mi. The enzyme was
added to human TBM (4 mg/mI in 0.5 N acetic acid) at an E/S
ratio of 10% (wet/wt), and incubated with stirring overnight at
4°C.
Trypsin. Trypsin (Worthington, TPCK, 236 units/mg) was
dissolved in 0.001 N HCI at concentration of 1 mg/mI. TBM was
suspended in 0.5 M Tris-HCI, pH 7.6 and trypsin solution was
added to give an E/S ratio of 1% (wet/wt). Digestion was carried
out at 37°C overnight with stirring.
To prepare the samples for gel electrophoresis, aliquots of the
digestion mixtures were precipitated at 4°C with a tenfold
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excess of ethanol. This was centrifuged, and the pellets dis-
solved in gel—electrophoresis sample preparation buffer.
Reduction and alkylation. Human TBM was reduced by the
addition of beta-mercaptoethanol (1 mmol per 3 to 4 mg TBM)
in 6 M guanidine-HC1, 0.05 M Tris-HCI, pH 8.5 in a boiling water
bath for 2 to 3 minutes. Following this, iodacetamide (2 mmol)
was added with stirring. The suspension was then clarified by
centrifugation, filtered, precipitated and prepared for electro-
phoresis analysis.
Electrophoresis analysis
Polyacrylamide gel electrophoresis was done in discontinu-
ous buffers in SDS using the procedures as described by
Laemmli [211.
Immunochemical methods
ELISA was done as previously described [22—24]. Antigen
was coated to a polystyrene microtiter plate in 0.2 M sodium
carbonate buffer, pH 9.5, overnight at ambient temperature.
Serum was diluted in 0.05 M sodium/potassium phosphate, pH
7.5, 0.15 M NaCI, 0.05% Tween 20, 0.2% bovine serum albumin
and incubated on the coated plates for one hour. Plates were
rinsed with 0.15 M NaCI, 0.05% Tween 20, incubated with
anti-human IgG-alkaline phosphatase conjugate for an hour,
then tested for enzyme activity using p-nitrophenyl phosphate
as substrate. Enzyme activity was measured by monitoring
absorbance at 405 nm. Assays were performed in triplicate.
Competitive ELISA was attempted by mixing equal volumes of
diluted antibody and antigen in the phosphate buffer, followed
by incubation at 4°C overnight. The incubate was then trans-
ferred onto coated microtiter plates, and incubated for one
hour. Plates were rinsed and incubated with conjugate and
substrate as above.
Immunoblot (Western blot) was carried out by transferring
electrophoresed material from PAGE onto 0.45 .tm nitrocellu-
lose paper [25]. Following transfer, the paper was blocked by
incubation in 0.2 M sodium carbonate, pH 9.5, containing 2%
bovine serum albumin for a minimum of one—half hour. Test
serum was diluted as above and incubated for a minimum of one
hour with the blocked nitrocellulose paper. The nitrocellulose
paper was rinsed and incubated with anti-human IgG-horserad-
ish peroxidase conjugate for a minimum of one hour, then
washed and enzyme activity was tested with H202-diaminoben-
zidine substrate. In some cases, blots were stained for protein
using India ink [26].
Molecular weight determination
Molecular weight measurements were made from protein
blots of electrophoresis gels. Samples and molecular weight
standards were run in duplicate and blotted onto nitrocellulose
paper. The paper was then cut, and one half was stained for
protein with India ink [26], and the other half was analyzed for
reactivity with TIN sera by overlay assays. Molecular weights
of reactive bands were determined by correlating the position of
bands detected by overlay assay with the duplicate blot stained
for protein. Molecular weight standards included bovine serum
albumin, ovalbumin, glyceraldehyde-3-phosphate and carbonic
anhydrase.
Antibody dilution, log
Fig. 1. Binding of serum antibodies from patients wit/I tubulointer-
stitial nephritis to tubular basement membrane. Human TBM was
extracted with 6 st guanidine HCI, 0.05 M Tris, pH 7.5, at 37°C
overnight. The solubilized protein was diluted 1 10 in carbonate buffer,
pH 9.0, and coated onto a microtiter plate using 20 g protein per well.
The reactivity of anti-TBM sera (top two curves) with the TBM extract
is compared by ELISA with normal human serum (bottom two curves)
at dilutions from 1:10 to 1:1024. Assays were performed in triplicate,
and the results represent the averages.
Results
Reaction of TBM extracts with TIN sera
Human TBM was extracted at 37°C in 6 M guanidine buffer
and in 6 or 8 M urea buffers in the presence of protease
inhibitors. Antigenic activity solubilized by guanidine as deter-
mined by ELISA is demonstrated by the antibody titration
curves presented in Figure 1. Antigen titration (not shown)
showed diminished reactivity with increasing dilution of the
antigen. Reactivity of the antisera with extracts of GBM was
not significantly above background. The results demonstrate
that the autoantibody from the TIN patients bind an antigen
present in guanidine extracts of TBM. Both sera have readily
detectable levels of TBM antibodies, whereas control sera are
consistently negative. When guanidine—insoluble TBM was
subsequently solubilized by reduction of disulfide bonds, only
traces of additional activity were detected. Reduction of
disulfide bonds in the guanidine soluble fraction did not alter its
reactivity with human TBM antibodies. This result demon-
strates that guanidine releases essentially all the antigen from
TBM and that its reactivity with the human TBM antibodies is
not altered by reduction. Urea extraction also was effective in
solubilizing the antigenic activity from TBM; however, about 15
to 25% remained in the insoluble matrix, as determined by
ELISA on guanidine extracts of urea—insoluble TBM and by
Western blot analysis performed on the various fractions.
Efforts were made to quantitate the extracted antigen in a
competitive ELISA. Extracts were diluted in 0.05 M phosphate,
pH 7.5, 0.15 M NaCI, 0.05% Tween-20, 0.2% bovine serum
albumin, then incubated with TIN sera. No competition was
realized, hence the antigen either failed to bind in solution
and/or dilution of the denaturant caused loss of reactivity.
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Fig. 2. Comparison of TBM antibodies, Goodpasture antibodies and
7S collagen antibodies for specificity toward TBM and GBM fractions.
ELISAs were performed on guanidine—solubilized TBM (A) and GBM
(C); and on the guanidine insoluble residue following digestion with
bacterial collagenase (B and D). B represents ELISAs performed on
guanidine—insoluble TBM digested with collagenase and D represents
guanidine—insoluble GBM digested with collagenase. The test sera
represented by lanes 1—5 in each panel (A—D) were as follows: lane 1,
normal human serum diluted 1:20, lane 2, TIN-i serum at 1:100; lane 3,
TIN-2 serum to 1:50, lane 4, Goodpasture serum at 1:50; and lane 5,
rabbit antiserum to 7S collagen at 1:500. ELISA measurements were
made in triplicate as described in Figure 1, using 10 sg of coating
antigen per well. Values represent the mean SD.
ELISAs designed to demonstrate binding and nonbinding of
antibodies in TIN sera to various basement membrane prepa-
rations are shown in Figure 2. These results indicate that both
TIN sera react with guanidine . HCI extracts of human TBM
(2A, lanes 2 and 3) but not with extracts of GBM (2C, lanes 2
and 3). Binding of antibody to guanidine extracts of human
GBM was not significantly greater than incubations with normal
human serum. Reactivity of TIN sera with collagenase diges-
tion products of guanidine—insoluble basement membranes was
not significantly greater than that of normal human serum and
therefore may be considered to be negative. This result is
consistent with the observation that guanidine solubilizes
nearly all of the antigenic activity from the TBM, hence
digestion of the guanidine insoluble fraction does not release
additional reactivity. Collagenase digestion of whole TBM, that
is, not previously extracted with guanidine, released only about
5 to 10% of the potential reactivity. Collectively, these results
are suggestive of a noncollagenous derivation of the TBM
antigen(s). Both the Goodpasture antigen and 7S collagen are
released from guanidine insoluble TBM upon collagenase diges-
tion (Figure 2B) indicating that Goodpasture antibodies and
antibodies toward 7S collagen are distinct from the TBM
antibodies.
Identification of a reactive TBM antigen by western blotting
Immuno-overlay analysis was used to further characterize
the antigen recognized by the TIN patient's sera. Both sera
showed a strong reaction with a Mr about 58,000 band in
SDS-soluble human TBM, whereas GBM was negative for this
component, as shown in Figure 3. Three faintly staining bands
Fig. 3. Western blot analysis demonstrating the presence of an antigen
in TBM that is reactive with human TBM antibodies. Lanes 1—3 in each
panel represent: 1) molecular weight standard protein mixture to
demonstrate the absence of nonspecific binding; 2) guanidine—extracted
human GBM and 3) guanidine—extracted human TBM. Samples of 2.5
sg extracted protein and 5 sg of each protein in the standard mixture
were applied to an electrophoresis gel. Following electrophoresis,
samples were blotted by electrophoretic transfer onto nitrocellulose
sheets. The nitrocellulose paper was then cut for incubation in normal
human serum (NHS); and with the human TBM antisera (TIN-I and
TIN-2) diluted 50x. The blots were developed with anti-human IgG-
horseradish peroxidase conjugate and H202-diaminobenzidine.
of Mr 100,000; 150,000 and 200,000 were also detected with the
two anti-TBM sera, but not with control sera. These bands were
seen in extracts of both TBM and GBM (Figs. 3 and 4B). The
latter result suggests that presence of antibodies specific for
components common to both TBM and GBM or nonspecific
binding to common components. Analysis of blots of antigen
extracted with either 6 M guanidine or 6 M urea in 0.05 M Tris,
pH 7.5 gave similar results. An intensely staining, Mr 58,000
antigen was always detected, and the three faintly staining
bands were generally observed. Figure 4A presents a blot of
guanidine solubilized human TBM and GBM (lanes 2 and 3)
stained for protein with India ink. Multiple protein bands
spanning a wide molecular weight range are detected with the
ink stain. The specificity of one anti-TBM serum for compo-
nents present in the guanidine extract is shown is 4B, lanes 1
and 2. The intensely staining band present in lane 2 is unique to
TBM, whereas the three very lightly staining bands (lanes 1 and
2) in the upper 1/3 of the gel profile are present in both the GBM
and TBM extracts. To determine whether disulfide bonds are
important to the integrity of the TBM antigen, human TBM was
reduced and alkylated, and analyzed by Western blotting (not
shown). The reduced TBM sample retained its reactivity with
the anti-TBM sera, and there was no change in its apparent
molecular weight.
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Fig. 4. Comparison of the reactivity of human TBM antibodies with extracted, and enzyme solubilized TBM; and comparison of reactivity among
species. A. Electrophoresis of 6M guanidine-HCI soluble human GBM (lane 2), human TBM (lane 3) and rabbit TBM (lane 4). Total protein was
stained with India ink. Lane I represents molecular weight standards consisting of: a) collagen I, alpha I chain; b) collagen I, alpha 2 chain; c)
bovine albumin, Mr 66,000; d) egg albumin, Mr 45,000; e) glyceraldehyde-3-phosphage dehydrogenase, Mr 36,000; and t) carbonic anhydase, Mr
29,000. B. Immuno-overlay analysis of protein blots of guanidine-HCI soluble human GBM and TBM (lanes I and 2), collagenase digested TBM
(lane 3) and trypsin digested TBM (lane 4). Samples of 5 g protein were applied to each lane in A and B. The overlay assay was done using the
high titer serum at 50x. C. Immuno-overlay analysis of: (1) molecular weight standard mixture, (2) SDS-solubilized human GBM; (3) human TBM;
(4) rabbit TBM; (5) rat IBM and (6) bovine TBM. Samples consisting of 2.5 j.g of SDS-soluble human GBM and TBM and 6.0 .sg each of
SDS-soluble rabbit, rat and bovine were applied to the gel represented in C.
Tubular basement membrane antigens in other species
In order to test for the presence of reactive TBM antigens in
nonhuman species, extracts of human, rabbit, rat and bovine
TBM were compared by ELISA and by immuno-overlay with
the highest titer anti-TBM serum. ELISA of guanidine extracts
demonstrated reactivity in the TBM from each of these species.
A complex distribution of protein constituents in the extracts
was seen for each species, as determined by SDS gel electro-
phoresis. The complexity of the extracted protein mixture from
human and rabbit TBM is shown in the ink stained protein blot
in Figure 4A, By contrast, the immuno-overlay analysis showed
a single major reactive band in the material extracted from the
TBM of each species examined (Fig. 4C). The reactive band
from human, rabbit and rat TBM had an apparent molecular
weight of 58,000; whereas the bovine antigen consistently gave
an apparent molecular weight of 56,000. Three lightly—staining
bands in the molecular weight range of 100,000 to 200,000 were
evident in some extracts of human GBM and TBM, and rabbit
IBM.
Protease sensitivity and partial purification
In an effort to find reactive protein fragments which might
correspond to the nephritogenic antigens identified by others
[11—14], whole human TBM (that is, non-extracted) was di-
gested with collagenase, trypsin, and pepsin. Following diges-
tion by these proteases, the reaction products were electropho-
resed, transblotted, and analyzed for protein and for reactivity
with anti-TBM sera. Although protein bands were evident in the
ink stained blots and in silver stained gels run simultaneously,
there was no binding of antibodies to the transblotted material
from trypsin and pepsin digests, and only traces of a Mr 58,000
band were seen in collagenase digests (Fig. 4B lanes 3 and 4;
pepsin digest not shown). This suggests that the antigen is either
destroyed by these proteases, or it is not released from the
TBM by these methods. To test the latter possibility, the
insoluble pellet remaining after digestion with the various
enzymes was extracted with 6 M urea and analyzed by immuno-
overlay. The extracts of the pellet remaining after trypsin and
pepsin digestion of TBM did not contain any reactive
polypeptides. The extracted pellet remaining following colla-
genase digestion contained a reactive polypeptide having of the
same mobility as the controls (not shown). By ELISA and
visual examination of the Western blots, the amount of antigen
present in the collagenase digestion pellet was the same as in
the controls. Thus it appears that collagenase is ineffective in
releasing significant amounts of the antigen from TBM whereas
trypsin and pepsin destroy it.
Immuno-overlay experiments suggest that the Mr 58,000
TBM component is the component primarily responsible for the
anti-TBM reactivity of the two human sera. It was important to
establish additional evidence for this, and to rule out the
possibility that reactivity might exist that would ordinarily
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escape detection by the immuno-overlay techniques, that is,
extremely large components would not penetrate a polyacryl-
amide gel, and extremely small ones would likely be lost during
blotting of electrophoresis gels. For this purpose, an 8 Murea,
0.1 M Tris HCI, pH 7.5 extract of human TBM was subjected to
gel filtration analysis on a column of Sepharose CL-4B. Frac-
tions eluted from the gel filtration column were monitored for
protein and for reactivity toward the high titer anti-TBM serum,
as shown in Figure 5. All of the ELISA reactivity was found in
the region where proteins of Mr 50,000 to 100,000 were eluted.
The reactivity was thus confined to the size range of reactivities
observed by immuno-overlay. Fractions from the gel filtration
column were then electrophoresed, and the presence of the M
58,000 reactive component was confirmed by immuno-overlay
(Fig. 5, insert lanes 3—6). The faintly staining higher molecular
weight components were also detected by this technique in the
gel filtration fractions (Fig. 5, inset lanes 1—3). The high molec-
ular weight components present in lanes I and 2 represent gel
filtration fractions 80 and 85, where no ELISA reactivity was
detected, suggesting that they may not react by ELISA. On the
basis of the present study we can conclude that the Mr 58,000
component accounts for nearly all of the reactivity with the
human anti-TBM sera, and that traces of reactivity with several
high molecular weight components ranging from 100,000 to
200,000 are also present. The M 58,000 reactive component is
unique to TBM whereas the trace reactive components are
present in both TBM and GBM.
Discussion
This study identifies a M 58,000 TBM component that is
bound by autoantibodies from two patients with anti-TBM
mediated TIN. The M 58,000 antigen accounts for nearly all of
the reactivity that can be detected by immuno-overlay analysis
of protein blots. ELISA of TBM extracts resolved by gel
filtration demonstrates that nearly all reactivity is present in
fractions in the molecular weight range of 50,000 to 100,000,
further supporting the conclusion that the M 58,000 component
is the nephritogenic antigen. Traces of reactivity toward TBM
and GBM components of Mr 100,000, 150,000 and 200,000 were
detected by immuno-overlay analysis. As monitored by
ELISA, the reactivity of the latter components was not signif-
icantly above background. The evidence for this comes from
analysis of GBM extracts which contain the reactive compo-
nents by immuno-overlay analysis (Fig. 4B) but are not reactive
by ELISA (Fig. 2). In addition, gel filtration fractions from
TBM extracts that contain only high molecular reactivities by
immuno-overlay analysis do not demonstrate significant reac-
tivity by ELISA. In view of their low reactivities and since they
are not TBM specific, it seems unlikely that these components
are important in the disease mechanism. This study does not
rule out the possible existence of antigens that do not react in
the immuno-overlay assay, but the present evidence suggests
that this is unlikely.
Reduction of its disulfide bonds did not change the electro-
phoretic mobility of the antigen, hence the protein probably
consists of a single polypeptide chain, and disulfide bonds are
not necessarily for its antigenicity. Reduction of the insoluble
residue following guanidine or urea extraction of TBM failed to
reveal any additional antigenically reactive proteins, although
this procedure solubilizes greater than 95% of the basement
membrane. Thus guanidine or urea extractions are sufficient to
solubilize all of the antigen of interest.
Several reports have described TBM antigens involved in
experimental and human TIN [11—141. The relationship among
the various antigens is not known at the present time. The
dissimilarity in their molecular weights (Mr 58,000 in this study
versus 70,000; 48,000 and 42,000 for collagenase solubilized
antigens and 30,000 for a trypsin solubilized antigen) is sugges-
tive of either multiple antigens or that various partial degrada-
tion products of a common antigen have been characterized. A
common feature of the more recently characterized antigens
[13, 141 is that they are apparently absent in certain animal
strains such as the Lewis rat. Indeed, the antibodies character-
ized in this study failed to bind Lewis rat kidney as analyzed by
indirect immunofluorescence microscopy. Furthermore, the
antigen has been identified in bovine, rabbit, guinea pig, rat,
mouse, as well as human kidneys by the combination of indirect
immunofluorescence analysis and immuno-overlay analysis.
This result suggests that the antigen identified in this study is a
highly conserved molecule that may correspond to the ones that
have recently been studied by Zanetti and Wilson [13] and
Clayman et al [14] in experimental models of TIN. Graindorge
and Mahieu prepared and characterized the first TBM antigen
recognized by antibodies from cases of human TIN [12]. Their
Mr 70,000 antigen was bound by antibodies from two patients
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Fig. 5. Partial fractionation by gel filtration of protein reactive with
human anti-TBM sera. Human TBM was extracted with 8 M urea, 0.1
M Tris-HCI, pH 8.5, and solubilized protein was concentrated and
applied to a Sepharose CL-4B column (4 x 90 cm). Column eluate was
monitored by absorbance at 230 nm (—) and for binding of antibodies
from the high titer serum (+—+) by ELISA. ELISA was performed in
triplicate and the average values are represented. The inset represents
column fractions that are reactive on immuno-overlay analysis. Lanes
1—6 represent column fractions 84, 90, 96, 100, 104, and 110, respec-
tively. The major reactive, Mr 58,000, component is indicated by the
arrow. Its appearance in the immuno-overlay coincides with the major
ELISA reactivity. The elution of high molecular components that are
reactive by immuno-overlay coincides with very low ELISA reactiv-
ities (lanes I and 2, representing fractions 84 and 90). Lane 7 represents
a sample of the starting material applied to the column.
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with TIN secondary to immune complex glomerulonephritis,
and it was also bound by antibodies from several cases of
glomerulonephritis that demonstrated linear GBM and TBM
staining and from cases of lupus nephritis. Like the antigen
identified in this study, their antigen is TBM specific. Although
the observed apparent molecular weight differs between their
antigen and the one identified here, it seems probable that we
are dealing with the same molecule. A seemingly less plausible
alternative is that two TBM specific antigens exist, one of which
is bound by antibodies form cases of primary TIN and another
by antibodies from cases of secondary TIN and other renal
diseases. Thus, the various antigens that have been identified
display features in common, but differences also exist, espe-
cially with respect to their molecular weights. In order to
unequivocally establish the relationships among the various
antigens, it will be necessary to purify at least one of them and
demonstrate their binding by antibodies in the various models
and human disease, or to establish the chemical identity (or
nonidentity) between the various purified antigens.
The antigens isolated by Graindorge and Mahicu [12] and
Clayman et al [14] are glycoproteins containing low levels of
4-hydroxyproline. The presence of 4-hydroxyproline in their
antigens, and the fact that they are solubilized by collagenase
suggests that they could be noncollagenous domains of colla-
genous molecules. By analogy, the Goodpasture antigen, as
solubilized by collagenase digestion, contains low levels of
4-hydroxyproline [25]. The Goodpasture antigen has been lo-
calized to the globular domain of collagen IV of GBM [271.
The extracts containing our antigen contain 4-hydroxyproline
[20] which would be consistent with a possible collagenous
origin for our extracted antigen; however, since the extracts
contain many other components, meaningful conclusions can-
not be made with respect to the composition of our antigen at
this point. On the other hand, evidence for a noncollagenous
origin for our antigen must be considered. While collagenase
releases some antigen, very little of its is solubilized by colla-
genase compared with the extraction procedure. That which is
solubilized by collagenase is of the same molecular weight by
SDS gel electrophoresis as extracted antigen, suggesting that
the effect of collagenase may be indirect, that is, collagenase
may effect solution of the antigen by degrading a collagenous
molecule to which the antigen is bound. Indeed, the presence of
4-hydroxyproline in the antigen preparation of Clayman et al
[14] could be due to the presence of collagenous molecules that
are associated with the antigen, and are not removed during
purification by immunoabsorption chromatography. Likewise,
the antigen prepared by Graindorge and Mahieu may be con-
taminated by other components of similar electrophoretic mo-
bility, since it was prepared by preparative gel electrophoresis.
Knowledge of the biochemical properties of this antigen is
prerequisite to an understanding of its function in the normal
kidney and its role in disease. It will thus be important to
develop methods to isolate the antigen in quantities sufficient to
perform detailed biochemical analyses. By use of the extraction
method of solubilization, it should be possible to obtain suffi-
cient quantities of antigen to permit its purification and analysis,
while avoiding the potential complications of the proteolytic
solubilization methods.
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